Barbara J. McNeil, MD, PhD; Andrew Witty, CEO; Dean Jeffrey Flier
Barbara J. McNeil, MD, PhD; Andrew Witty, CEO of GSK; HMS Dean Jeffrey S. Flier, MD
GlaxoSmithKline’s CEO, Andrew Witty, gives talk at Harvard Medical School

On Friday, February 13, 2009, Andrew Witty presented “Big Pharma as a Catalyst for Change,” to Harvard faculty, students and staff. For a detailed summary of his talk, please visit the following link (pdf).